Diabetes reduces vascular tetrahydrobiopterin levels by oxidation: Insights from a GTPCH-transgenic mouse model
Prif Awduron: | Alp, N, Mussa, S, Goh, N, Cai, S, Channon, K |
---|---|
Fformat: | Conference item |
Cyhoeddwyd: |
2003
|
Eitemau Tebyg
-
Increased endothelial tetrahydrobiopterin levels in GTPCH-transgenic mice
gan: Alp, N, et al.
Cyhoeddwyd: (2002) -
Increased endothelial tetrahydrobiopterin levels by GTPCH over expression in transgenic mice prevents diabetic endothelial dysfunction
gan: Alp, N, et al.
Cyhoeddwyd: (2003) -
Reduced levels of tetrahydrobiopterin in diabetic mouse model: Effects on endothelial function and nitric oxide (NO) synthase dimerisation
gan: Cai, S, et al.
Cyhoeddwyd: (2004) -
Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I over-expression
gan: Alp, N, et al.
Cyhoeddwyd: (2003) -
Nitric oxide Bioavailability is preserved in diabetes by increased endothelial tetrahydrobiopterin synthesis in targeted GTP cyclohydrolase transgenic mice
gan: Alp, N, et al.
Cyhoeddwyd: (2003)